Home › GSK raises $853 million by halving stake in South African drugmaker
 

Keywords :   


GSK raises $853 million by halving stake in South African drugmaker

2015-03-13 12:04:30| Biotech - Topix.net

GlaxoSmithKline has taken profits in Aspen Pharmacare by selling half its stake in the South African drugmaker for $853 million , following a long investment in the firm. The sale, which was conducted through a share placing at a discount to the market price, is the latest example of GSK pruning non-core investments as it refocuses its business and works to protect its sizeable dividend payments to shareholders.

Tags: south million african raises

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
11.06Unemployment rate highest for more than two years
11.06Eastern North Pacific Tropical Weather Outlook
11.06Atlantic Tropical Weather Outlook
11.06Singapore Airlines offers to pay turbulence victims
11.06Mini China parts probe expanded by US Senate panel
11.06Eastern North Pacific Tropical Weather Outlook
11.06Atlantic Tropical Weather Outlook
11.06Why the EU might be about to make Chinese electric cars more expensive
More »